Imitinef Mercilet Medicine for Blood Cancer. “Adyar Cancer Institute is distributing This Medicine Free “, This News Spreading Thru Social Media is it true ?
I know that most of all hear about this Free Medicine Imitinef Mercilet for Blood Cancer is available in Adyar Cancer Institute. Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. This medicine is Free of charge for only selected peoples (Those who passed the criteria of Cancer Institute) and should admitted in the hospital for treatment.
Adyar Cancer Institute itself they cleared this. This is the secular ( given below in red letters ) from the hospital about this news.
THE MESSAGE FROM ADYAR CANCER INSTITUTE
FOR YOUR KIND ATTENTION
‘’ It has been noticed that an information is being circulated through the internet as ” Emails and as Facebook ” posts regarding the availability of a certain medicine called ‘Imitinef mercilet’at the Cancer Institute, Adyar, Chennai. The message also often makes the statement about this drug curing all blood cancers and it being offered free of charge at the Cancer Institute. We want to make it clear that this is a misleading message being circulated. We believe that the drug name mentioned is a distortion of the drug called ‘imatinib mesylate’ which is a drug used to treat a type of blood cancer called ‘chronic myeloid leukemia’. This drug is available all over India and is being prescribed at all Cancer Centres and is not exclusive to the Cancer Institute, Adyar, Chennai. The drug support programme is also active in all major cancer centres in the country.
Hence people who come across the misleading message via internet are requested not to circulate it.’’
Adyar Cancer Institute is a cancer specialty hospital situated in the city of Chennai, India; founded by Dr. Muthulakshmi Reddy on June 18, 1954 on the Land donated by Mr. S. K. Puniyakoti Mudaliar. The institute has been rated by the World Health Organisation (WHO) as the Top Ranking Centre in the country